Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion type Assertion NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_head.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion description "[It is important to evaluate the effects of proposed interventions to reduce the risk of disease among carriers of a highly penetrant mutation, such as the mutations in BRCA1 and BRCA2 for breast and ovarian cancers or in APC and MLH1 or MSH2 for colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_provenance.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion evidence source_evidence_literature NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_provenance.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion SIO_000772 15316055 NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_provenance.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion wasDerivedFrom befree-2016 NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_provenance.
- NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_assertion wasGeneratedBy ECO_0000203 NP456357.RAEljv4T64ybyQzeiBdsY04-VAd4UhJyn4hUvRqULir1Q130_provenance.